Anti-Covid Pill Cleared, But Will India Place Bulk Orders?
NDTV
A World Health Organisation, or WHO, programme aims to get the drugs for as little as $10 dollars (over Rs 700 approximately) per course eventually
The next big breakthrough in the fight against COVID-19 is here and India has a chance to be among the first nations to manufacture billions of doses of a series of new anti-viral pills.
The first drug is called Molnupiravir, developed by Merck. This anti-Covid drug is now being manufactured by 13 Indian firms and has been cleared for use by the government.
In the last few months, Pfizer and Merck have developed Paxlovid and Molnupiravir, respectively. The two pills have shown extremely high efficacy in anti-COVID-19 therapy.
On November 5, Pfizer said Paxlovid cut hospitalisation rates by nearly 90 per cent.
